Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2.523
Zitationen
16
Autoren
2016
Jahr
Abstract
peer reviewed
Ähnliche Arbeiten
Risk of Ischemic Heart Disease in Women after Radiotherapy for Breast Cancer
2013 · 3.923 Zit.
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 · 3.713 Zit.
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
2022 · 2.647 Zit.
Low-Molecular-Weight Heparin versus a Coumarin for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer
2003 · 2.521 Zit.
Risk Factors for Doxorubicin-lnduced Congestive Heart Failure
1979 · 2.431 Zit.